Quick Answer
Edwards Lifesciences Corp reported Gross Profit of $4.73 billion for fiscal year 2025.
Edwards Lifesciences Corp Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $4.73B | +9.5% |
| 2024 | $4.32B | +7.2% |
| 2023 | $4.03B | +7.8% |
| 2022 | $3.74B | -6.1% |
| 2021 | $3.98B | +20.5% |
| 2020 | $3.31B | +2.2% |
| 2019 | $3.23B | +16.2% |
| 2018 | $2.78B | +8.7% |
| 2017 | $2.56B | +18.2% |
| 2016 | $2.17B | +15.4% |
| 2015 | $1.88B | +10.6% |
| 2014 | $1.70B | +11.0% |
| 2013 | $1.53B | +8.5% |
| 2012 | $1.41B | +18.5% |
| 2011 | $1.19B | +14.5% |
| 2010 | $1.04B | +12.6% |
| 2009 | $922.30M | +12.7% |
| 2008 | $818.10M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.21B | +10.7% | +1.7% |
| June 30, 2025 | $1.19B | +8.6% | +6.9% |
| March 31, 2025 | $1.11B | +6.5% | +1.8% |
| September 30, 2024 | $1.09B | +9.9% | -0.2% |
| June 30, 2024 | $1.09B | +5.3% | +4.9% |
| March 31, 2024 | $1.04B | -7.7% | +5.1% |
| September 30, 2023 | $992.80M | -6.8% | -4.4% |
| June 30, 2023 | $1.04B | -6.0% | -8.1% |
- Edwards Lifesciences Corp showed an increase of +9.5% in Gross Profit compared to the prior fiscal year.
- Over the 2008–2025 period, Edwards Lifesciences Corp’s gross profit has grown by 478.6% (from $818.10 million to $4.73 billion).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: